| Larry H Killebrew, MD | |
|
4500 13th St, Gulfport, MS 39501-2515 | |
| (228) 865-3151 | |
| (228) 867-4124 |
| Full Name | Larry H Killebrew |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 46 Years |
| Location | 4500 13th St, Gulfport, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265514301 | NPI | - | NPPES |
| 00119198 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 08371 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Highland Community Hospital | Picayune, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Keystone Medical Services Of Ms Inc | 7618075177 | 8 |
News Archive
Researchers say the protein - Serum surfactant protein A - is superior to other IPF predictors and could lead to better decisions about treatment and timing of lung transplantation.
Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
Older people who have higher blood pressure may have more signs of brain disease, specifically brain lesions, according to a study published in the July 11, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment.
› Verified 5 days ago
| Entity Name | Keystone Medical Services Of Ms Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174691059 PECOS PAC ID: 7618075177 Enrollment ID: O20070606000447 |
News Archive
Researchers say the protein - Serum surfactant protein A - is superior to other IPF predictors and could lead to better decisions about treatment and timing of lung transplantation.
Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
Older people who have higher blood pressure may have more signs of brain disease, specifically brain lesions, according to a study published in the July 11, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment.
› Verified 5 days ago
| Entity Name | Mississippi Emergency Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710220678 PECOS PAC ID: 2264672492 Enrollment ID: O20130710000827 |
News Archive
Researchers say the protein - Serum surfactant protein A - is superior to other IPF predictors and could lead to better decisions about treatment and timing of lung transplantation.
Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
Older people who have higher blood pressure may have more signs of brain disease, specifically brain lesions, according to a study published in the July 11, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment.
› Verified 5 days ago
| Entity Name | Keystone Medical Services Of Gulfport Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881070183 PECOS PAC ID: 7113221011 Enrollment ID: O20160215000517 |
News Archive
Researchers say the protein - Serum surfactant protein A - is superior to other IPF predictors and could lead to better decisions about treatment and timing of lung transplantation.
Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
Older people who have higher blood pressure may have more signs of brain disease, specifically brain lesions, according to a study published in the July 11, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment.
› Verified 5 days ago
| Entity Name | App Of Mississippi Ed Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730687740 PECOS PAC ID: 3971865858 Enrollment ID: O20180313002534 |
News Archive
Researchers say the protein - Serum surfactant protein A - is superior to other IPF predictors and could lead to better decisions about treatment and timing of lung transplantation.
Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
Older people who have higher blood pressure may have more signs of brain disease, specifically brain lesions, according to a study published in the July 11, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment.
› Verified 5 days ago
| Entity Name | Singing River Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861010159 PECOS PAC ID: 5294154829 Enrollment ID: O20201001001497 |
News Archive
Researchers say the protein - Serum surfactant protein A - is superior to other IPF predictors and could lead to better decisions about treatment and timing of lung transplantation.
Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
Older people who have higher blood pressure may have more signs of brain disease, specifically brain lesions, according to a study published in the July 11, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment.
› Verified 5 days ago
| Entity Name | Rh Emergency Medicine Of Marion General Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841064110 PECOS PAC ID: 0648623744 Enrollment ID: O20240124004763 |
News Archive
Researchers say the protein - Serum surfactant protein A - is superior to other IPF predictors and could lead to better decisions about treatment and timing of lung transplantation.
Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
Older people who have higher blood pressure may have more signs of brain disease, specifically brain lesions, according to a study published in the July 11, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment.
› Verified 5 days ago
| Entity Name | Rh Emergency Medicine Of Highland Community Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033987946 PECOS PAC ID: 4587017918 Enrollment ID: O20240201000844 |
News Archive
Researchers say the protein - Serum surfactant protein A - is superior to other IPF predictors and could lead to better decisions about treatment and timing of lung transplantation.
Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
Older people who have higher blood pressure may have more signs of brain disease, specifically brain lesions, according to a study published in the July 11, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Larry H Killebrew, MD 4500 13th St, Gulfport, MS 39501-2515 Ph: (228) 865-3151 | Larry H Killebrew, MD 4500 13th St, Gulfport, MS 39501-2515 Ph: (228) 865-3151 |
News Archive
Researchers say the protein - Serum surfactant protein A - is superior to other IPF predictors and could lead to better decisions about treatment and timing of lung transplantation.
Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
Older people who have higher blood pressure may have more signs of brain disease, specifically brain lesions, according to a study published in the July 11, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment.
› Verified 5 days ago
Michael E Moses, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 15190 Community Rd, Suite250, Gulfport, MS 39503 Phone: 228-539-8100 | |
David Jason Bailey, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1312 44th Ave, Gulfport, MS 39501 Phone: 228-539-5858 | |
Joseph A Graham, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Avenue, Suite 220, Gulfport, MS 39501 Phone: 228-575-1300 Fax: 228-867-6423 | |
Amy Lynn Scheller, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd, Gulfport, MS 39503 Phone: 228-539-0489 | |
Donald Allan Balder, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 11070 David St, Gulfport, MS 39503 Phone: 228-265-5945 Fax: 228-284-1580 | |
Kristine Marie Carter, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave, Suite 240, Gulfport, MS 39501 Phone: 228-575-1200 Fax: 228-575-1205 |